DEREK JANTZ - 07 Jun 2021 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Scientific Officer, Director
Signature
/s/ Dario Scimeca, Attorney-in-Fact for Derek Jantz
Issuer symbol
DTIL
Transactions as of
07 Jun 2021
Net transactions value
$0
Form type
4
Filing time
09 Jun 2021, 18:25:55 UTC
Previous filing
19 May 2021
Next filing
07 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Employee Stock Option (Right to Buy) Award $0 +101,537 $0.000000 101,537 07 Jun 2021 Common Stock 101,537 $11.34 Direct F1
transaction DTIL Restricted Stock Units Award $0 +59,090 $0.000000 59,090 07 Jun 2021 Common Stock 59,090 Direct F2, F3
transaction DTIL Employee Stock Option (Right to Buy) Award $0 +62,875 $0.000000 62,875 07 Jun 2021 Common Stock 62,875 $11.34 Direct F4
transaction DTIL Restricted Stock Units Award $0 +36,590 $0.000000 36,590 07 Jun 2021 Common Stock 36,590 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date. Any unvested options shall vest and become exercisable upon the Reporting Person's termination without cause or resignation due to good reason prior to June 7, 2022.
F2 The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
F3 The RSUs shall vest in two equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Any unvested RSUs shall vest upon The Reporting Person's termination without cause or resignation for good reason prior to June 7, 2022.
F4 The option vests as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date.
F5 The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.